A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells

A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells

Abstract Background Chronic limb-threatening ischemia (CLTI) represents the final stage of peripheral arterial disease. Approximately one-third of patients with CLTI are not eligible for conventional surgical treatments. Furthermore, patients with advanced stage of CLTI are prone to amputation and d...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Martha L. Arango-Rodríguez, Ligia C. Mateus, Claudia L. Sossa, Silvia M. Becerra-Bayona, Víctor Alfonso Solarte-David, Miguel Enrique Ochoa Vera, Lady T. Giratá Viviescas, Ana M. Vera Berrio, Sergio Eduardo Serrano, Oliverio Vargas, Andrés Catalá Isla, Alape Benitez, Germán Rangel
Format: Artikel
Sprache:English
Veröffentlicht: BMC 2023-08-01
Schriftenreihe:Stem Cell Research & Therapy
Schlagworte:
Peripheral arterial disease
Chronic limb-threatening ischemia
Cell therapy
Autologous bone marrow mononuclear cells and allogenic Wharton jelly-derived mesenchymal stem cells
Online Zugang:https://doi.org/10.1186/s13287-023-03427-z

Online

https://doi.org/10.1186/s13287-023-03427-z

Ähnliche Einträge